Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.38 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | MPI | P34949 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | CASP6 | P55212 | 1/20 | 0.37 |
| ▸ | JUN | P05412 | 2/20 | 0.34 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.34 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.34 |
| ▸ | RELA | Q04206 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methyl Alcohol SCHEMBL28649214 | 0.94 | CYP1A2 (0.41) | CYP1A2CYP3A4CYP2D6CYP2C19TYRO3 | |
| SCHEMBL3395853 | 0.82 | CYP1A2 (0.40) | CYP1A2CYP3A4CYP2D6CYP2C19ALDH1A1 | |
| SCHEMBL5677080 | 0.80 | JUN (0.42) | CYP1A2CYP3A4CYP2D6CYP2C19TYRO3 | |
| SCHEMBL29954024 | 0.78 | CYP1A2 (0.46) | CYP1A2CYP3A4CYP2D6CYP2C19ALDH1A1 | |
| SCHEMBL22174810 | 0.78 | CYP1A2 (0.38) | CYP1A2CYP3A4CYP2D6CYP2C19ALDH1A1 | |
| SCHEMBL20987584 | 0.78 | CYP1A2 (0.38) | CYP1A2CYP3A4CYP2D6CYP2C19ALDH1A1 | |
| SCHEMBL5674156 | 0.78 | CYP1A2 (0.46) | CYP1A2CYP3A4CYP2D6CYP2C19ALDH1A1 | |
| SCHEMBL27103191 | 0.78 | CSNK1A1 (0.46) | CYP1A2CYP3A4CYP2D6CYP2C19TYRO3 | |
| SCHEMBL23457248 | 0.77 | TYRO3 (0.34) | TYRO3DYRK1BALDH1A1KDM4ESMN1; SMN2 | |
| SCHEMBL1916761 | 0.77 | TYRO3 (0.34) | TYRO3DYRK1BALDH1A1KDM4EJUN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 370 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121574134-A | Preparation method of treasipril and salt thereof | 济南圣泉集团股份有限公司 | 2026-02-27 | — | — | CN | claimed |
| CN-110903250-B | Process for preparing 2, 4-dichloro-5-pyrimidinecarbaldehyde and derivatives thereof | 安庆博曼生物技术有限公司 | 2022-11-18 | — | — | CN | claimed |
| CN-113429411-A | Preparation method of 1-alkyl-6-chloro-1H-pyrazolo [3,4-d ] pyrimidine compound | 韶远科技（上海)有限公司 | 2021-09-24 | — | — | CN | claimed |
| CN-110903250-A | Preparation method of 2, 4-dichloro-5-pyrimidine formaldehyde and derivatives thereof | 安庆博曼生物技术有限公司 | 2020-03-24 | — | — | CN | claimed |
| CN-102180880-A | Method for synthesizing bromophenyl pyrazolo[3,4-d]pyrimidine derivative | UNIV CHANGZHOU | 2011-09-14 | — | — | CN | claimed |
| CN-102115476-A | 2H-pyrazolo [3, 4-d] pyrimidine derivative and synthetic method thereof | UNIV CHANGZHOU | 2011-07-06 | — | — | CN | claimed |
| CN-102115475-A | Method for synthesizing pyrazolo[3,4-d]pyrimidine derivative by two steps | UNIV CHANGZHOU | 2011-07-06 | — | — | CN | claimed |
| EP-0131545-B1 | REACTIVE DYES, THEIR PREPARATION AND THEIR USE | CIBA-GEIGY AG (CH) | 1988-04-20 | — | — | EP | claimed |
| EP-0130711-B1 | AQUEOUS SOLUTIONS OF REACTIVE DYES | ICI AMERICAS INC. (US) | 1987-02-11 | — | — | EP | claimed |
| EP-0179019-A1 | Reactive dyes, their preparation and their use | CIBA-GEIGY AG (CH) | 1986-04-23 | — | — | EP | claimed |
| US-4560388-A | WITH SULFO GROUP CONTAINING FIBER REACTIVE DYE | CIBA-GEIGY CORPORATION (US) | 1985-12-24 | — | — | US | claimed |
| US-4544738-A | FIBER-REACTIVE YELLOW AND ORANGE DYES | BASF AKTIENGESELLSCHAFT (DE) | 1985-10-01 | — | — | US | claimed |
| US-4472168-A | STORAGE STABILITY BUFFERED SOLUTIONS | ICI AMERICAS INC. (US) | 1984-09-18 | — | — | US | claimed |
| US-3933785-A | Azo compounds | CIBA-GEIGY AG (CH) | 1976-01-20 | — | — | US | claimed |
| US-20260138991-A1 | SEMI-SATURATED BICYCLIC DERIVATIVES AND RELATED USES | MOMA THERAPEUTICS INC (US) | 2026-05-21 | — | — | US | disclosed |
| US-12624024-B2 | EP2 antagonist compounds | RESERVOIR NEUROSCIENCE, INC. (US) | 2026-05-12 | — | — | US | disclosed |
| CN-121949329-A | Preparation method of treasipril and salt thereof | 济南圣泉集团股份有限公司 | 2026-05-01 | — | — | CN | disclosed |
| US-3971738-A | Heavy metal complexes of azo compounds containing a halogeno-2,3-dihydroxy pyridine coupling component | CIBA-GEIGY AG (CH) | 1976-07-27 | — | — | US | disclosed |
| US-3957751-A | WATER-SOLUBLE REACTIVE DYESTUFFS OF THE MONOAZO SERIES CONTAINING AN ACTIVE METHYLENE COUPLING COMPONENT | HOECHST AKTIENGESELLSCHAFT (DT) | 1976-05-18 | — | — | US | disclosed |
| US-3933785-A | Azo compounds | CIBA-GEIGY AG (CH) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260138991-A1 | SEMI-SATURATED BICYCLIC DERIVATIVES AND RELATED USES | POLA1, SUB1, CTDSP1 | CYP1A2 180/4885CYP3A4 334/4885CYP2D6 31/4885 |
| US-12624024-B2 | EP2 antagonist compounds | PTGER1, PTGER2, PTGER4 | CYP1A2 405/4885CYP3A4 734/4885CYP2D6 377/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.